2-(Dimethylamino)ethyl 4-(butylamino)benzoate
Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 5411.
Registration
- Applicants
- 1
- Registrations
- 2
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| The Premier Pharmaceutical Co Ltd1 of 2 cancelled | Dynexan | ointment, powder | G2266, H1069 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Dynexan ointment EACH 100 G OINTMENT CONTAINS: AMETHOCAINE HYDROCHLORIDE A 0,5 G | Ointment | G2266 | Old Medicine | Not determined | None |
| Dynexan powder EACH 100 g CONTAINS AMETHOCAINE HYDROCHLORIDE A 535 mg ARNICA FLOWER A 0,099 g CHAMOMILE FLOWERS A 0,274 g COPPER PHAEOPHYTIN A 6,0 mg SAGE A 0,198 g | Powder | H1069 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Tetracaine
- when intended for ophthalmic or parenteral use;
- except when intended for topical use; (S1)
- except in oral preparations containing 2 percent or less of Tetracaine; (S1)
- except when contained in eye drops intended for the emergency treatment of “arc eyes”. (S2)
Consolidated Schedules 06 July 2026, lines 8152 to 8160
S2: Tetracaine
- when contained in eye drops intended for the emergency treatment of “arc eyes”
- except when intended for topical use; (S1)
- except in oral preparations containing 2 percent or less of tetracaine, per dosage unit; (S1)
- except when intended for ophthalmic or parenteral use. (S4)
Consolidated Schedules 06 July 2026, lines 2707 to 2715
S1: Tetracaine
- when intended for topical use;
- in oral preparations containing 2 percent or less of tetracaine, per dosage unit;
- except when contained in eye drops intended for the emergency treatment of “arc eyes”; (S2)
- except when intended for ophthalmic or parenteral use. (S4)
Consolidated Schedules 06 July 2026, lines 1096 to 1104
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.